New pill aims to curb excessive urination in rare genetic disorder
NCT ID NCT07525960
First seen Apr 20, 2026 · Last updated May 19, 2026 · Updated 7 times
Summary
This early-stage trial tests a daily capsule called NDI-5001 in 24 adult men with a rare inherited kidney condition that causes extreme thirst and urination. The main goal is to check safety and how the drug affects urine output and concentration. Participants must have a confirmed genetic mutation and low urine concentration at the start.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for X-LINKED CONGENITAL NEPHROGENIC DIABETES INSIPIDUS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.